Cel Sci (CVM) Intangibles (2010 - 2026)
Cel Sci (CVM) posted Intangibles of $73000.0 for Q1 2026, down 28.43% sequentially from $102000.0 in Q4 2025, and down 48.23% YoY from $141000.0 in Q1 2025.
Cel Sci (CVM) Intangibles (2010 - 2026) Analysis & Trends
Cel Sci has reported Intangibles for 16 years, with the latest figure at $73000.0 in Q1 2026.
- Quarterly Intangibles fell 48.23% year-over-year to $73000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73000.0 (down 48.23% YoY) and the FY2025 annual result came in at $119856.0, down 27.58% from the prior year.
- Intangibles declined to $73000.0 in Q1 2026 per CVM's latest filing, from $102000.0 in the prior quarter.
- Over five years, Intangibles peaked at $234658.0 in Q1 2022 and troughed at $73000.0 in Q1 2026.
- A 5-year average of $168570.5 and a median of $180482.0 in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2024 and 2026: Intangibles decreased 5.45% in 2024, then plunged 48.23% in 2026.
- Over 5 years, Intangibles stood at $202000.0 in 2022, then dropped by 6.93% to $188000.0 in 2023, then slipped by 21.28% to $148000.0 in 2024, then slumped by 31.08% to $102000.0 in 2025, then declined by 28.43% to $73000.0 in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $73000.0, $102000.0, and $119856.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | - |
| 10 | Cel Sci | 2.16 Mn | -4.37 Mn | - | 70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | 119,856.00 |
| Jun 30, 2025 | 130,585.00 |
| Mar 31, 2025 | 141,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Sep 30, 2024 | 165,492.00 |
| Jun 30, 2024 | 173,028.00 |
| Mar 31, 2024 | 180,482.00 |
| Dec 31, 2023 | 188,000.00 |
| Sep 30, 2023 | 197,704.00 |
| Jun 30, 2023 | 183,000.00 |
| Mar 31, 2023 | 192,231.00 |
| Dec 31, 2022 | 202,000.00 |
| Sep 30, 2022 | 212,201.00 |
| Jun 30, 2022 | 222,462.00 |
| Mar 31, 2022 | 234,658.00 |
| Dec 31, 2021 | 247,521.00 |
| Sep 30, 2021 | 275,866.00 |
| Jun 30, 2021 | 279,366.00 |